The AI Healthcare Divide: What Davos 2026 Missed About Global Inequality
Davos 2026 was wall-to-wall AI talk. Whether you were listening to heads of state or CEOs, the conversation kept circling back to how…
-
-
The Biggest Pharmacogenomics Advances of 2025 — Year in Review
As 2025 comes to a close, pharmacogenomics has firmly stepped out of its former niche and into the spotlight as a research-driven catalyst…
-
AlphaFold and the Future of Precision Drugs
For decades, biology has faced a fundamental challenge: understanding how the information encoded in our genes translates into the physical machinery of life….
-
Is Pharmacogenomics Paired with AI the Antidote to the Global Cardiovascular Crisis?
Cardiovascular disease remains the world’s leading cause of death, claiming close to 20 million lives each year, with cases continuing to rise across…
-
Clinicians in Saudi Arabia “Know About” Pharmacogenomics, New Study Finds
Pharmacogenomics, or PGx, is changing medicine worldwide. The idea is simple: the right drug should match a person’s genes. But turning this idea…
-
New UK Guideline: Clopidogrel Now Requires Genetic Testing
The UK has taken a major step forward in precision prescribing with the publication of its first national pharmacogenomic guideline, focused on the…
-
Machine Learning for pharmacogenomic variant effect predictions: Insights From a Recent Review
In the last decade, pharmacogenomics (PGx) has moved from a niche research domain into a central pillar of precision medicine. Sequencing is now…
-
Vega, Sirius, &The Future of Pharmacogenomics
Drug prescribing is entering a new chapter. For decades, clinicians have relied on broad guidelines, trial-and-error approaches, and limited genetic information to determine…
-
OneOme to Shutdown, Deal a Blow to PGx Industry Momentum
OneOme, a leading name in pharmacogenomics testing and personalized medicine, has announced that it will cease operations by November 14, 2025, citing ongoing…
-
The Three Key Factors Driving the Rise of Preemptive Pharmacogenomics
For years, pharmacogenomics (PGx) was seen as a future promise, a fascinating science that could someday make drug therapy safer and more effective….
End of content
End of content